Noncultivable acid-fast bacilli that circulate in the bloodstream of patients with untreated lepromatous leprosy are viable as judged by their capacity to multiply in the mouse footpad in a manner typical for Mycobacterium leprae. The continuous presence of up to 105 viable leprosy bacilli/ml of blood both reflects and helps to explain the extreme widespread nature of infection in patients with lepromatous leprosy. Rifampin “kills” M. leprae (i.e., inhibits multiplication in the mouse footpad) much more rapidly than does dapsone, but leprosy bacteremia persists for at least 12–16 weeks with either form of therapy. Circulating M. leprae are viable for up to six weeks after initiation of dapsone, but for fewer than four weeks after rifampin. Either dead M. leprae continue to circulate in treated patients, or the footpad technique is not sufficiently sensitive to detect low concentrations of viable M. leprae.